- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 14/555 - Interférons (IFN)
Détention brevets de la classe C07K 14/555
Brevets de cette classe: 290
Historique des publications depuis 10 ans
|
11
|
23
|
21
|
22
|
27
|
18
|
22
|
24
|
25
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Opko Biologics Ltd. | 75 |
13 |
| The Regents of the University of California | 19517 |
10 |
| Evotec International GmbH | 83 |
9 |
| Sanofi | 3951 |
8 |
| Superlab Far East Limited | 18 |
7 |
| Werewolf Therapeutics, Inc. | 49 |
7 |
| Toray Industries, Inc. | 6855 |
6 |
| Rutgers, The State University of New Jersey | 1844 |
6 |
| Orionis Biosciences Inc. | 92 |
6 |
| The Industry & Academic Cooperation in Chungnam National University (IAC) | 431 |
5 |
| Novagen Holding Corporation | 26 |
5 |
| The Board of Trustees of the Leland Stanford Junior University | 6246 |
4 |
| CytomX Therapeutics, Inc. | 217 |
4 |
| Regeneron Pharmaceuticals, Inc. | 3986 |
4 |
| Universiteit Gent | 1321 |
4 |
| Vib VZW | 846 |
4 |
| Akseera Pharma Corp. | 10 |
4 |
| The Trustees of the University of Pennsylvania | 4260 |
3 |
| Alios BioPharma, Inc. | 67 |
3 |
| Memed Diagnostics Ltd. | 78 |
3 |
| Autres propriétaires | 175 |